Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol

Diabetes Technol Ther. 2018 Sep;20(9):571-575. doi: 10.1089/dia.2018.0246. Epub 2018 Aug 21.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Clinical Protocols
  • Diabetes Mellitus, Type 1 / complications
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Diabetic Ketoacidosis / chemically induced
  • Diabetic Ketoacidosis / prevention & control*
  • Humans
  • Sodium-Glucose Transporter 2 Inhibitors / adverse effects*

Substances

  • Sodium-Glucose Transporter 2 Inhibitors